News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
News|Articles|December 30, 2024

Our Top 5 Social Media Posts of 2024

Author(s)Miranda Schmalfuhs

Check out our top five most engaged social media posts from the year 2024.

Advertisement

1.

2.

3.

4.

5.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Stock.adobe.com

Pharmaceutical Executive Daily: Amgen Acquires Dark Blue Therapeutics for $840 Million

ByNicholas Jacobus
January 7th 2026
Stock.adobe.com

FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices

ByNicholas Jacobus
January 7th 2026
Rakers Lin

Skinny Labeling: Origins, Evolution, and Key Decisions

ByLeanne Rakers
January 7th 2026
Stock.adobe.com

GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications

ByNicholas Jacobus
January 7th 2026
Image Credit: Adobe Stock Images/natali_mis

Taming the Complexity of CGT Commercialization: 5 Keys to a Workable Operating Model

ByVishal Singal
January 7th 2026
Advertisement
Advertisement

Trending on PharmExec

1

Nimbus Therapeutics and Eli Lilly Enter $1.3 Billion License Agreement and Research Collaboration for Oral Obesity Treatments

2

Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.

3

Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction

4

The Real Value Equation: How Humans and AI Create and Destroy Value in Pharma

5

Pharmaceutical Executive Daily: Alnylam Invests $250 Million in Manufacturing Facility

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us